JACQUELYN GARVIN: Open Payments
NPI 1275937153 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$980 in 44 payments from 13 companies in 2025. Trend: 2023 $889 · 2024 $837 · 2025 $980
Food & beverage: $980
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 19 | $419 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $92 |
| SHIELD THERAPEUTICS INC | 1 | $92 |
| Evofem Biosciences, Inc. | 4 | $78 |
| Astellas Pharma US Inc | 3 | $71 |
| MILLICENT US INC | 3 | $59 |
| Exeltis, USA Inc. | 3 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Dexcom, Inc. | 1 | $21 |
| Hologic Sales and Service, LLC | 1 | $21 |
Products named: ZURZUVAE, ACCRUFER, Phexxi, Veozah, FEMLYV, SLYND, MYFEMBREE, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
